Summary
Q/R editing of the kainate receptor (KAR) subunit GluK2 radically alters recombinant KAR properties, but the effects on endogenous KARs in vivo remain largely unexplored. Here, we compared GluK2 editing-deficient mice that express ∼95% unedited GluK2(Q) to wild-type counterparts that express ∼85% edited GluK2(R). At mossy fiber-CA3 (MF-CA3) synapses GluK2(Q) mice displayed increased postsynaptic KAR function and KAR-mediated presynaptic facilitation, demonstrating enhanced ionotropic function. Conversely, GluK2(Q) mice exhibited reduced metabotropic KAR function, assessed by KAR-mediated inhibition of slow after-hyperpolarization currents (ISAHP). GluK2(Q) mice also had fewer GluA1-and GluA3-containing AMPA receptors (AMPARs) and reduced postsynaptic AMPAR currents at both MF-CA3 and CA1-Schaffer collateral synapses. Moreover, long-term potentiation of AMPAR-mediated transmission at CA1-Schaffer collateral synapses was reduced in GluK2(Q) mice. These findings suggest that GluK2 Q/R editing influences ionotropic/metabotropic balance of KAR signaling to regulate synaptic expression of AMPARs and plasticity.
Subject areas: Biological sciences, Neuroscience, Cellular neuroscience
Graphical abstract

Highlights
-
•
GluK2(Q) mice display enhanced EPSCKA and reduced EPSCAMPA
-
•
Mutant mice show a global reduction in GluA1 and GluA3 subunits of AMPARs
-
•
KAR mediated inhibition of IsAHP is reduced in GluK2(Q) mice
-
•
LTP at Schaffer collateral-CA1 synapses is reduced in mutant mice
Biological sciences; Neuroscience; Cellular neuroscience
Introduction
Kainate receptors (KARs) are glutamate-gated cation channels assembled from tetrameric combinations of the subunits GluK1-GluK5. Depending on the synapse and neuron type, KARs are present at both pre- and postsynaptic sites throughout the brain.1 Despite their close homology to AMPA- and NMDA-type glutamate receptors, postsynaptic KARs mediate only a minor fraction of the ionotropic synaptic response to glutamate, but they are critically important for synaptic integration and regulation of neural circuits.2,3,4 Presynaptic KARs also contribute to neuronal network function by regulating neurotransmitter release probability at both excitatory and inhibitory synapses.5,6,7,8,9,10,11,12
KARs have been particularly well studied at hippocampal glutamatergic MF-CA3 synapses,13,14 where the GluK2 subunit is an integral component of both pre- and postsynaptic KARs.6,7,8,15,16,17 Indeed, ionotropic postsynaptic KARs containing GluK2 were first discovered at MF-CA3 synapses,13,14,15 and GluK2-containing KARs were shown to contribute to short-term plasticity of presynaptic release probability over timescales ranging from 10ms to 20s.18,19
In addition to ionotropic actions, KARs also initiate G protein-coupled metabotropic signaling.20,21,22,23,24 Metabotropic signaling through postsynaptic KARs has been demonstrated at Schaffer collateral-CA1 synapses25 and at MF-CA3 synapses.16,26 Synaptic activation of postsynaptic KARs inhibits the slow after hyperpolarization (IsAHP), a long-lasting voltage-independent and Ca2+-dependent K+ current produced following short bursts of action potentials.27 KAR-mediated inhibition of IsAHP occurs in multiple neuronal types via a Gi/o G protein and PKC-dependent pathway and, in CA3 cells, is absent in GluK2 knockout mice, suggesting a crucial role for this subunit in this form of metabotropic signaling.16,25,26,28 Furthermore, pharmacological activation of KARs by exogenous agonists regulates presynaptic release of both GABA and glutamate through this metabotropic pathway.20,29,30,31,32
KAR surface expression is activity-dependently and bidirectionally regulated.24,33,34,35,36,37 Furthermore, activation of KARs can also up- or down-regulate AMPAR surface expression to mediate plasticity.24,38 Specifically, transient activation of GluK2-containing KARs in cultured hippocampal neurons increases AMPAR surface expression, and in hippocampal slices GluK2-containing KARs can induce AMPAR long-term potentiation (KAR-LTPAMPAR) at Schaffer collateral-CA1 synapses via a pertussis toxin-sensitive metabotropic signaling pathway.24 In contrast, sustained activation of KARs reduces surface expression of AMPARs in cultured hippocampal neurons and induces AMPAR long-term depression in CA1 neurons in hippocampal slices (KAR-LTDAMPAR), an effect that is lost in the absence of GluK2.38 These results highlight the importance of GluK2-containing KARs as modulators of AMPAR-mediated synaptic transmission.
The nuclear enzyme ADAR2 Q/R edits GluK2 pre-mRNA, resulting in a genetically encoded glutamine (Q) in the channel pore region being replaced by an arginine (R).39,40 In recombinant systems KARs containing GluK2(R) subunits display ER retention and reduced traffic to the cell surface compared to those assembled with the unedited GluK2(Q).41,42 Furthermore, the edited GluK2(R)-containing KARs that do reach the surface do not gate Ca2+ and have a channel conductance <1% of GluK2(Q).43
The dynamic regulation of GluK2 Q/R editing underpins KAR homeostatic plasticity whereby chronic suppression of network activity decreases ADAR2 levels. This, in turn, reduces GluK2 editing resulting in enhanced KAR surface expression. Reciprocally, chronic enhancement of network activity promotes GluK2 Q/R editing and reduces KAR surface expression.35,36,37
We used electrophysiology and biochemistry approaches to investigate how GluK2 Q/R editing alters KAR signaling and function in intact neuronal circuits and whether these changes, in turn, regulate AMPAR function. GluK2 editing-deficient mice contain a deletion in the intronic editing complementary sequence (ECS) of the grik2 gene that directs ADAR2-mediated codon substitution in the GluK2 pre-mRNA (Figure 1A). This results in >95% of GluK2-KARs in adult mice containing unedited GluK2(Q), whereas KARs in WT mice contain <15% GluK2(Q).44 Importantly, however, Q/R editing of the GluK1 KAR subunit, and the GluA2 AMPAR subunit, are un-altered in these mice.44 GluK2(Q) mice are viable and, as expected, surface expressed KARs in cultures from these mice display the inwardly rectifying current/voltage (I-V) relationship characteristic of GluK2(Q)-containing KARs expressed in recombinant systems.45,46 The only previous study using these GluK2(Q) mice detected no differences in GluK2 mRNA levels, no alterations in editing of the other GluK2 editing sites (I/V and Y/C) and no change in Q/R editing of the GluA2 AMPAR subunit.44 However, the GluK2(Q) mice were reported to have increased susceptibility to kainate-induced seizures and display a form of NMDAR-independent LTP at the medial perforant-DG synapses that is not present in WT mice.44
Figure 1.
Enhanced postsynaptic KAR and reduced AMPAR currents at MF-CA3 synapses in GluK2(Q) mice
(A) The intronic region between exon 12 (M2) and 13 (M3) in the grik2 gene contains an editing complementary site (ECS), located ∼1900nt downstream of exon 12. In the WT mice, this region is intact. However, in homozygous GluK2(Q) mice, a 600bp region is deleted from the ECS site. This prevents ADAR2 binding and subsequent editing of GluK2 pre-mRNA at the Q/R site, leading to the translation of >95% unedited GluK2(Q) subunits.
(B) Representative data from a minimal stimulation experiment showing stimulation intensity threshold for evoking responses from excitation of a single axon fiber (left). Eight superimposed consecutive traces showing synaptic successes and failures for minimal stimulation for WT (red) (top right) and GluK2(Q) mice (blue) (bottom right).
(C) Quantification of probability of failures for AMPAR responses out of 150 stimulations in WT and GluK2(Q) mice. N = 5, n = 8 cells for WT and N = 5, n = 10 cells for GluK2(Q) mice; ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
(D) Quantification of average amplitude of EPSCAMPA (left). Representative trace showing EPSCAMPA in WT (red) and GluK2(Q) mice (blue) (right).N = 5, n = 8 cells for WT and N = 5, n = 10 cells for GluK2(Q) mice (bottom).; ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
(E) Representative trace showing EPSCKA in WT (red) and GluK2(Q) mice (blue) (top). Quantification of average amplitude of EPSCKA (bottom). N = 5, n = 8 cells for WT and N = 5, n = 10 cells for GluK2(Q) mice (bottom); ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
(F) Representative trace showing τdecay for KAR currents (WT scaled to Tg) in WT (red) versus GluK2(Q) mice (blue) (top) Quantification of τdecay for KAR currents in WT vs. GluK2(Q) mice. N = 5, n = 8 cells for WT and N = 5, n = 10 cells for GluK2(Q) mice (bottom); ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
(G) Representative traces showing postsynaptic AMPAR (blue) and KAR (purple) currents in WT and GluK2(Q) mice with minimal stimulation (top). Quantification of KAR/AMPAR current ratio in WT (red) and GluK2(Q) mice (blue) (bottom) N = 5, n = 8 cells for WT and N = 5, n = 10 cells for GluK2(Q) mice, ns p > 0.05, ∗∗∗∗p < 0.0001; unpaired t-test with Welch’s correction.
(H) Representative traces showing postsynaptic AMPAR (blue) and KAR (purple) currents in WT and GluK2(Q) mice with burst stimulation at 167Hz (top). Quantification of KAR/AMPAR current ratio in WT (red) and GluK2(Q) mice (blue) (bottom). N = 5, n = 12 cells, ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
Here, we show enhanced pre- and postsynaptic KAR ionotropic function in the GluK2(Q) mice compared to WT controls whereas metabotropic KAR-mediated inhibition of IsAHP was reduced. Furthermore, in GluK2(Q) mice AMPAR-mediated transmission at hippocampal CA3 and CA1 synapses, synaptic levels of GluA1 and GluA3 were decreased and LTP at CA1 Schaffer collateral synapses was severely attenuated. We interpret these data to indicate that GluK2 editing is important for determining the mode of KAR signaling, and that this, in turn, plays key roles in the regulation of basal expression of synaptic AMPARs and AMPAR-mediated synaptic plasticity.
Results
Enhanced postsynaptic KAR and reduced AMPAR currents at MF-CA3 synapses in GluK2(Q) mice
In recombinant systems KARs containing unedited GluK2(Q) have a higher conductance than edited GluK2(R).43,47 Moreover, disrupting ADAR2-mediated GluK2 Q/R editing enhances the surface expression, single channel conductance, and Ca2+ permeability of postsynaptic KARs in cultured neurons.36,43,48 Therefore, we measured basal KAR-mediated postsynaptic responses at MF-CA3 synapses in WT and GluK2(Q) mice. Because both the glutamate receptor complement and presynaptic facilitation at MF-CA3 synapses are stable after the 2nd postnatal week49,50 we used P14-P21 mice and confirmed the stability of AMPAR and KAR expression within this age range.
To compare between GluK2-editing deficient and WT genotypes, we used a well-established minimal stimulation protocol to isolate monosynaptic responses at 3Hz in acutely prepared hippocampal slices.49,51,52,53 Postsynaptic responses were recorded from CA3 pyramidal neurons in whole-cell voltage clamp configuration in the presence of picrotoxin (50μM) and D-APV (50μM) to block GABAARs and NMDARs, respectively. The stimulation intensity applied to presynaptic axons was increased in small increments until a postsynaptic response was observed (Figure 1B). Interestingly, the percentage of trials that evoked a synaptic response (success rate) was decreased in the GluK2(Q) mice (Figure 1C) (WT = 43 ± 5%, GluK2(Q) = 27 ± 1%; unpaired t-test, p = 0.017), suggesting either a decrease in the number of release sites or reduced probability of glutamate release from the same number of sites. Furthermore, the average AMPAR-EPSC amplitude for successful trials was reduced in GluK2(Q) mice (Figure 1D) (WT = 94.5 ± 8.8pA, GluK2(Q) = 59.1 ± 3.5pA; unpaired t-test, p = 0.0044).
The AMPAR antagonist GYKI53655 (40μM) was then applied to pharmacologically isolate KAR-mediated excitatory postsynaptic currents (EPSCKA) evoked by single presynaptic mossy fiber axons. Analysis of detectable synaptic responses revealed that EPSCKA was increased in amplitude in GluK2(Q) mice (Figure 1E) (WT = 4.66 ± 0.63pA, GluK2(Q) = 7.31 ± 0.50pA; unpaired t-test, p = 0.0057), but with no change in decay kinetics (Figure 1F) (τdecay, WT = 16.0 ± 1.5ms, GluK2(Q) = 13.9 ± 1.1ms; unpaired t-test, p = 0.28), consistent with enhanced conductance of unedited GluK2(Q)-containing recombinant KARs.43,47
We also measured the EPSCKA to EPSCAMPA amplitude ratio for both minimal and larger EPSCs evoked by bursts of 3 stimuli at 167Hz given to mossy fiber axons that stimulate multiple axons.54 This stimulation protocol was chosen to maximize the KAR response.26 EPSCAMPA was first collected in the presence of picrotoxin (50μM) and D-APV (50μM) to block GABAARs and NMDARs, respectively. Then, EPSCAMPA was blocked by bath application of GYKI53655 (40μM) for 10 min to isolate EPSCKA. The EPSCKA/EPSCAMPA ratio increased in GluK2(Q) mice (Figures 1G and 1H) (minimal stimulation: WT = 0.049 ± 0.005, GluK2(Q) = 0.12 ± 0.007; unpaired t-test, p = 0.0001; 167Hz stimulation: WT = 0.047 ± 0.005, GluK2(Q) = 0.086 ± 0.008; unpaired t-test, p = 0.0008). Based on the minimal stimulation data for EPSCKA and EPSCAMPA, this increase in KAR/AMPAR ratio likely results from an increase in EPSCKA, and a decrease in EPSCAMPA.
Enhanced presynaptic facilitation in GluK2(Q) mice
Presynaptic KARs at MF-CA3 synapses are autoreceptors activated by released glutamate to facilitate the probability of vesicle release in response to subsequent action potentials.8,55,56,57 To investigate how GluK2 Q/R editing affects presynaptic KAR function at MF-CA3 synapses, we measured short-term facilitation of presynaptic release in the presence of picrotoxin (50μM) across a range of timescales. By measuring EPSCAMPA, we examined paired-pulse facilitation (PPF), observed at 50ms stimulation intervals, and accumulation of frequency facilitation (FF), observed by changing the frequency of stimulation from 50ms to 1s intervals, in acute slices from WT and GluK2(Q) mice using previously described protocols.15,18,19,58 Both PPF and FF were increased in GluK2(Q) mice (Figures 2A and 2B) (PPF: WT = 3.3 ± 0.2, GluK2(Q) = 5.3 ± 0.6; un-paired t-test, p = 0.0067; FF: WT = 4.5 ± 0.4, GluK2(Q) = 6.6 ± 0.6; unpaired t-test, p = 0.0114), consistent with enhanced presynaptic KAR function and/or decreased basal release probability.
Figure 2.
Enhanced presynaptic facilitation in GluK2(Q) mice
(A) Quantification of average paired-pulse ratio in WT (red) and GluK2(Q) mice (blue)(left). Representative traces showing EPSCs in response to paired-pulse stimulation from both WT and GluK2(Q) mice before (top right) and after DCG-IV application (bottom right). WT, N = 7, n = 13 cells; GluK2(Q) mice, N = 8, n = 15 cells; ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
(B) Representative trace showing frequency facilitation from WT and GluK2(Q) mice (top). Timeline of frequency facilitation experiments in WT and GluK2(Q) mice (bottom left). Quantification of frequency facilitation in WT and GluK2(Q) mice (bottom right).
(C) Percentage of DCG-IV block in WT and GluK2(Q) mice. WT, N = 7, n = 13 cells; GluK2(Q) mice, N = 8, n = 15 cells; ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
In all experiments the purity of mossy fiber input was determined by addition of the group II metabotropic glutamate receptor agonist DCG-IV (2μM)59 and recordings were excluded if there was <70% inhibition of synaptic responses. Furthermore, to exclude the possibility that differences in the purity of mossy fiber inputs contributed to the enhanced short-term facilitation in GluK2(Q) mice we analyzed the degree of DCG-IV inhibition. No differences were observed (Figure 2C) (WT = 91.5 ± 2.1%, GluK2(Q) = 93.2 ± 1.2%; unpaired t-test, p = 0.4879) and there was no correlation between degree of inhibition by DCG-IV and PPR (Figures S1A and S1B) (WT, r = 0.277, R2 = 0.0769, p = 0.383; GluK2(Q), r = −0.280, R2 = 0.0784, p = 0.378; 95% confidence interval). There was also no correlation between EPSC amplitude and PPR (Figures S1C and S1D) (WT, r = 0.127, R2 = 0.0163, p = 0.692; GluK2(Q), r = 0.0383, R2 = 0.00147, p = 0.906; 95% confidence interval). EPSC initial amplitudes in response to the first stimulus were set to be similar between genotypes (WT = 156.6 ± 14.4pA, GluK2(Q) = 143.9 ± 17.8pA; unpaired t-test, p = 0.5830).
Taken together with the reduced success rate observed in the minimal stimulation experiments (Figure 1C), these data suggest that basal release probability is reduced, and presynaptic facilitation is enhanced, at MF-CA3 synapses in GluK2(Q) mice.
Metabotropic KAR function is impaired in GluK2(Q) mice
Because the GluK2 Q/R editing site is within the channel pore region it is unsurprising that editing impacts on KAR ionotropic signaling but the effects of Q/R editing on metabotropic signaling have not been investigated. We therefore assessed if GluK2 Q/R editing alters metabotropic function by measuring KAR inhibition of the slow afterhyperpolarization current (IsAHP) in acute hippocampal slices.16,25,26,60 IsAHP currents were evoked in whole-cell voltage clamped CA3 pyramidal cells by depolarizing the membrane potential to 0mV from −50mV for 200ms in the presence of 50μM picrotoxin, 50μM D-APV, 40μM GYKI53655 and 1μM CGP55845 to inhibit GABAARs, NMDARs, AMPARs and GABABRs, respectively.26 Robust and stable IsAHP currents were obtained in both WT and GluK2(Q) mice, with no difference in baseline amplitudes between genotypes (Figure 3A) (WT = 67.0 ± 8.0pA, GluK2(Q) = 63.1 ± 6.6pA; unpaired t-test, p = 0.712). Activation of synaptic KARs by MF stimulation (10 stimuli at 25Hz every 20 s for 10 mins), as previously described,26,61 produced a consistent depression of IsAHP in WT mice but the extent of depression was decreased in GluK2(Q) mice (Figure 3B) (WT = 45.1 ± 3.7%, GluK2(Q) = 26.7 ± 2.7%; unpaired t-test, p = 0006). These data indicate that KAR metabotropic signaling is impaired in GluK2(Q) mice.
Figure 3.
Impaired metabotropic KAR function in GluK2(Q) mice
(A) Average baseline amplitude of IsAHP currents in WT (red) and GluK2(Q) (blue) mice.
(B) Sample traces from WT before (red) and after synaptic KAR stimulation (green) (top left) and GluK2(Q) mice (blue) before and after synaptic KAR stimulation (top middle) and EPSCKA following synaptic stimulation (top right). Timeline showing inhibition of IsAHP following synaptic KAR activation (bottom left). Quantification of percentage inhibition of IsAHP following synaptic KAR activation in WT and GluK2(Q) mice (bottom right). N = 4 animals, n = 13 cells, ns p > 0.05, ∗∗p < 0.0001; un-paired t-test with Welch’s correction.
Synaptic expression of KAR subunits is altered in GluK2(Q) mice
The reduced metabotropic signaling in GluK2(Q) mice could arise from disrupted molecular signaling and/or reduced expression of synaptic KARs. We therefore assessed total and synaptosomal expression of key KAR subunits in WT and GluK2(Q) mice by western blotting. Total expression of the GluK1, GluK2 and GluK5 was unaltered in GluK2(Q) mice (Figure 4A) (GluK1: WT = 100 ± 8.6%, GluK2(Q) = 95.7. ± 8.5%, unpaired t-test, p = 0.73; GluK2: WT = 100 ± 8.1%, GluK2(Q) = 140.6 ± 18.5 unpaired t-test, p = 0.07; GluK5: WT = 100.0 ± 9.8%, GluK2(Q) = 108.4 ± 10.8%, unpaired t-test, p = 0.57).
Figure 4.
Altered synaptic KAR subunit expression in GluK2(Q) mice
(A) Representative Western blots of total and synaptosomal fraction samples from a single cerebral hemisphere of WT or GluK2(Q) mice for KAR subunits (left). Quantification of proteins expressed as percentage of WT protein after normalizing to β -actin (right). β-actin was used as a loading control. N = 7 animals; ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
(B) Representative Western blots of total and synaptosomal fraction samples from a single cerebral hemisphere of WT or GluK2(Q) mice for auxiliary KAR subunits Neto1 and Neto2 (left) Quantification of proteins expressed as percentage of WT protein after normalizing to β-actin (right). β-actin was used as a loading control N = 7; ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
In synaptosomes, however, the expression of GluK1 and GluK2 was reduced whereas expression of GluK5 was increased (Figure 4A) (GluK1: WT = 100 ± 351%, GluK2(Q) = 69.0 ± 5.3%, unpaired t-test, p = 0.0006; GluK2: WT = 100 ± 3.5%, GluK2(Q) = 82.7 ± 5.1, unpaired t-test, p = 0.002; GluK5: WT = 100.0 ± 5.3%, GluK2(Q) = 122 ± 6.0%, unpaired t-test, p = 0.01). These data indicate that the enhanced pre- and postsynaptic ionotropic KAR function demonstrated in (Figures 1 and 2) are likely attributable to the increased conductance of GluK2(Q)-containing KARs, rather than an increase in the number of synaptic KARs.
Since most postsynaptic KARs comprise heteromeric combinations of GluK2/GluK5 and the auxiliary subunits Neto1 and/or Neto2, depending on the cell type,62 we next investigated the expression levels of the Neto1 and Neto2. Neither total (Neto1: WT = 100 ± 10.5%, GluK2(Q) = 114.0 ± 25.4%, unpaired t-test, p = 0.62; Neto2: WT = 100 ± 19.1%, GluK2(Q) = 118.9 ± 29.0%, unpaired t-test, p = 0.59) nor synaptic expression of Neto1 and Neto2 were altered in the GluK2(Q) mice (Neto1: WT = 100 ± 8.17%, GluK2(Q) = 113.4 ± 12.6%, unpaired t-test, p = 0.39; Neto2: WT = 100 ± 9.4%, GluK2(Q) = 69.8 ± 14.4%, unpaired t-test, p = 0.11) (Figure 4B),.
Reduced synaptic AMPAR expression in GluK2(Q) mice
Given that GluK2(Q) mice display a reduction in the EPSCAMPA (Figure 1D) we next stripped the same blots and reprobed for total and synaptic expression of AMPARs. Intriguingly, total (GluA1: WT = 100 ± 2.9%, GluK2(Q) = 67.4 ± 8.7%, unpaired t-test, p = 0.009; GluA3: WT = 100 ± 6.5%, GluK2(Q) = 37.3 ± 2.8%, unpaired t-test, p = 0.006) and synaptosomal levels of the AMPAR subunits GluA1 and GluA3 were reduced, (GluA1: WT = 100 ± 4.8%, GluK2(Q) = 65.1 ± 3.0%, unpaired t-test, p = 0.0001; GluA3: WT = 100 ± 4.2%, GluK2(Q) = 52.7 ± 3.3%, unpaired t-test, p = 0.002) (Figure 5A). In contrast, levels of GluA2 were unchanged in both total (WT = 100 ± 9.9%, GluK2(Q) = 73.4 ± 9.6%, unpaired t-test, p = 0.08) and synaptosome fractions (WT = 100 ± 7.7%, GluK2(Q) = 118.2 ± 23.4%, unpaired t-test, p = 0.4).
Figure 5.
Reduced synaptic AMPAR expression in GluK2(Q) mice
(A) Representative Western blots of total and synaptosomal fraction samples from a single cerebral hemisphere of WT or GluK2(Q) mice for the AMPAR subunits GluA1-3 (left). Quantification of proteins expressed as percentage of WT protein after normalizing to β-actin (right). β-actin was used as a loading control. N = 7 animals; ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
(B) Representative Western blots of total and synaptosomal fraction samples from a single cerebral hemisphere of WT or GluK2(Q) mice for the NMDAR subunits GluN1 and GluN2A (left). Quantification of proteins expressed as percentage of WT protein after normalizing to β-actin (right). β-actin was used as a loading control N = 6 animals (B); ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
We also tested NMDARs and found that although a reduction in the total levels of synaptically localized GluN2A was observed (Figure 5B) (GluN1: WT = 100 ± 10.8%, GluK2(Q) = 106.1 ± 26.7%, unpaired t-test, p = 0.8; GluN2A: WT = 100 ± 17.7%, GluK2(Q) = 44.2 ± 5.2%, unpaired t-test, p = 0.02), no changes were detected in the synaptic expression of GluN2A or the obligatory NMDAR subunit GluN163 in GluK2(Q) mice (Figure 5B) (GluN1: WT = 100 ± 11.2%, GluK2(Q) = 70.6 ± 11.2%, unpaired t-test, p = 0.09; GluN2A: WT = 100 ± 5.5%, GluK2(Q) = 87.7 ± 8.2%, unpaired t-test, p = 0.2).
These data indicate that impairments in GluK2 Q/R editing alter synaptic levels of both KARs and AMPARs, but not NMDARs.
Impaired LTP at Schaffer collateral-CA1 synapses in GluK2(Q) mice
Since we observed a global reduction in the levels of AMPARs in the GluK2(Q) mice, we next characterized CA1 synapses by stimulation of a single presynaptic Schaffer-collateral axon at 1Hz in acutely prepared hippocampal slices.49 Postsynaptic responses were recorded from CA1 pyramidal neurons in whole-cell voltage clamp configuration in the presence of picrotoxin (50μM) and D-APV (50μM) to block GABAARs and NMDARs. As described for MF-CA3 synapses (Figure 1), stimulation intensity of presynaptic axons was increased until a postsynaptic response was observed (Figure 6A). The percentage of trials that failed to evoke a synaptic response (failure rate) was the same for both WT and GluK2(Q) mice (Figure 6B) (WT = 0.60 ± 0.05%, GluK2(Q) = 0.69 ± 0.04%; unpaired t-test, p = 0.2). However, consistent with MF-CA3 synapses and the loss of AMPARs from the synaptosomes, the average AMPAR-EPSC amplitude for successful trials was reduced in GluK2(Q) mice (Figure 6C) (WT = 28.8 ± 1.7pA, GluK2(Q) = 19.2 ± 1.8pA; unpaired t-test, p = 0.002).
Figure 6.
Impaired LTP at Schaffer collateral-CA1 synapses in GluK2(Q) mice
(A) Representative data from a minimal stimulation experiment in CA1 showing stimulation intensity threshold for evoking responses from excitation of a single axon fiber (left). Eight superimposed consecutive traces showing synaptic successes and failures for minimal stimulation for WT (red) (top right) and GluK2(Q) (blue) mice (bottom right).
(B) Quantification of probability of failures for AMPAR responses out of 150 stimulations in WT and GluK2(Q) mice. N = 6, n = 7 cells for WT and N = 5, n = 7 cells for GluK2(Q) mice; ns p > 0.05; unpaired t-test with Welch’s correction.
(C) Quantification of average amplitude of EPSCAMPA (left). Representative trace showing EPSCAMPA in WT and GluK2(Q) mice (right). N6, n = 7 cells for WT and N = 5, n = 7 cells for GluK2(Q) mice; ns p > 0.05, ∗p < 0.05, ∗∗p < 0.01; unpaired t-test with Welch’s correction.
(D) Representative traces showing field EPSPs (fEPSP) before and after LTP induction (21–30 min) in WT (top left) and GluK2(Q) mice (middle). Schematics of mouse hippocampal slice, demonstrating CA1, CA3 and positions of recording and stimulating electrodes (top right). Timeline showing fEPSP slope expressed as percentage of baseline subjected to Ripple-Like (RL)-LTP induction (arrow) (bottom left). Normalized fEPSP slope in test pathway 21–30 min after LTP induction in WT and GluK2(Q) mice (bottom right). N = 4 animals, n = 7 cells; ns p > 0.05, ∗∗p < 0.002, ∗∗∗p < 0.0002, ∗∗∗∗p < 0.0001; Un-paired t-test with Welch’s correction.
(E) Paired-pulse ratio in WT and GluK2(Q) mice before and after LTP induction. N = 4 animals, n = 7 cells; ns p > 0.05, ∗∗p < 0.002, ∗∗∗p < 0.0002, ∗∗∗∗p < 0.0001; two-way ANOVA with Sidak’s multiple comparison test.
These results further confirm the role of GluK2 Q/R editing in maintaining AMPAR-mediated synaptic transmission and indicate that this phenomenon occurs at different hippocampal synapses.
Since GluK2 editing prevents Ca2+ entry through the KAR ion channel we wondered if predominant expression of unedited GluK2(Q), which traffic more efficiently and gate Ca2+, would reveal EPSCKAR at Schaffer collateral synapses. However, no EPSCKAR were detected following bursts of 3 stimuli at 167Hz given to Schaffer collaterals to drive multiple axons (Figure S2).
We next tested if the reduced synaptic expression of GluA1-and GluA3-containing AMPARs observed in GluK2(Q) mice impacted on the expression of long-term potentiation (LTP). We have previously shown that sharp-wave/ripple like (RL) patterns of activity induce LTP at Schaffer collateral-CA1 synapses that is expressed by increased AMPAR at the synapse, and therefore chose this synapse for these experiments.24 Extracellular field potential recordings from acute hippocampal slices revealed that high frequency stimulation that replicates the in vivo patterns of hippocampal RL activity24,64 induced robust LTP of AMPAR-mediated EPSPs in WT mice but LTP was significantly reduced in GluK2(Q) mice (Figure 6D) (WT: 172.8 ± 10.4% in test pathway vs. 97.7 ± 3.8% in control pathway; unpaired t-test, p = 0.0002; GluK2(Q): 133.8 ± 3.6% in test pathway vs. 97.2 ± 4.9% in control pathway; unpaired t-test; p = 0.0001; comparison between test pathways, unpaired t-test, p = 0.0087). The paired-pulse ratio remained unchanged after induction of LTP in both WT and GluK2(Q) mice (Figure 6E) (WT = 2.04 ± 0.14 baseline, 1.74 ± 0.17 after LTP, p = 0.325; GluK2(Q) = 2.13 ± 0.14 baseline, 1.95 ± 0.11 after LTP, p = 0.65; two-way ANOVA with Sidak’s multiple comparison test). These data suggest that preventing KAR Q/R editing reduces basal synaptic AMPAR expression and impairs the synaptic recruitment of AMPARs required for LTP.
Discussion
GluK2 Q/R editing is developmentally40,65 and activity-dependently regulated35,36 to modulate and accommodate distinct synaptic and network diversity. However, how GluK2 editing impacts on KAR function and subsequent downstream AMPAR function has not been explored. To address these outstanding questions we compared WT mice, which contain <15% unedited GluK2(Q), and GluK2 Q/R editing deficient (GluK2(Q)) mice that have >95% unedited GluK2(Q).44
In recombinant expression systems KARs containing unedited GluK2(Q) gate Ca2+ and have a much greater single channel conductance than those containing edited GluK2(R) (∼150ps compared to <10ps).43 We therefore predicted that postsynaptic ionotropic KAR function would be enhanced in GluK2(Q) mice. We found this to be the case, but the increase in EPSCKA we observed (WT = 4.66 ± 0.63pA, GluK2(Q) = 7.31 ± 0.50pA) was markedly less than expected based on the data from heterologous expression systems. However, it should be noted that, to our knowledge there is no available information in the literature on how heteromeric KARs containing GluK2(Q) or GluK2(R) subunits behave when combined with GluK4/GluK5 in invivo conditions. Moreover, recombinant KARs in heterologous cell lines generally lack auxiliary subunits and/or interacting proteins (e.g., Netos, KRIP6) that play crucial roles in regulating KAR localization, gating, and function.1 Thus, it is likely that cell-line based recombinant KAR systems exhibit different properties to endogenous KARs in primary cultured neurons or cultured ex vivo slices.
We also anticipated that the increased conductance and Ca2+ permeability of GluK2(Q)-containing KARs should boost presynaptic KAR function, resulting in enhanced short-term facilitation at both 50ms (PPF) and 1s (FF) timescales. This is indeed what we found in the mice, but we also observed an increase in failure rate in the minimal stimulation experiments. These data suggest an additional factor of reduced basal probability of release, or number of release sites, within the large presynaptic mossy fiber boutons, which on its own is predicted to increase presynaptic facilitation. Minimal stimulation at 3Hz is sufficient to engage KAR-mediated FF and would therefore be expected to produce a lower failure rate in GluK2(Q) mice. We observed the opposite effect, suggesting that the reduction in basal probability of release is substantial. Our data cannot distinguish between reduced probability of release and reduced number of release sites so further anatomical investigation would be necessary to address this. Nonetheless, overall, our data indicate that GluK2(Q) mice exhibit enhanced pre- and postsynaptic KAR function.
In stark contrast to their enhanced ionotropic KAR function, GluK2(Q) mice show reduced metabotropic function measured by inhibition of IsAHP at MF-CA3 synapses.16,25,26,60 Since IsAHP controls the excitability of CA3 pyramidal neurons and response to synaptic stimulation,26 GluK2(Q) is predicted to cause a reduction in the regulation of synaptic integration by KARs. Possible explanations for the diminished metabotropic KAR signaling in GluK2(Q) mice include a reduction in expression of GluK1 and GluK2 KAR subunits and/or Q/R editing state-dependent conformational changes which regulate metabotropic signaling. It remains unclear and controversial which, and how, specific KAR subunits contribute to KAR metabotropic signaling. Indeed, it has been proposed by different groups that GluK1, GluK2, or GluK5 are required for G protein coupling and metabotropic effects.16,21,24,34,66 Thus, although we cannot draw definitive mechanistic conclusions, our data demonstrate that GluK2(Q) mice show reduced metabotropic KAR signaling and, at the same time, enhanced ionotropic function.
Pre- and postsynaptic KARs induce bidirectional plasticity.6,8,24,38,67 Presynaptic KARs at MF-CA3 synapses induce LTD that is sensitive to Ca2+ levels suggesting a direct activation of ionotropic KARs or activation of voltage-gated Ca2+ channels through metabotropic KAR signaling.68 A critical role for postsynaptic KAR signaling is activity-dependent regulation of both KAR and AMPAR surface expression. For example, depending on the extent of activation, KARs can enhance or reduce AMPAR surface expression to evoke LTP or LTD via metabotropic or ionotropic signaling, respectively.24,38 Our data also show that GluK2 editing impacts on NMDAR-induced LTP at Schaffer collateral synapses in CA1, with GluK2(Q) mice exhibiting reduced LTP. GluK2(Q) mice also had reduced AMPAR-EPSCs at mossy fiber and Schaffer collateral synapses and lower GluA1 and GluA3 levels in synaptosomal fractions, suggesting that KARs not only regulate activity-dependent AMPAR trafficking but may also maintain basal synaptic levels of Ca2+-permeable AMPARs.
It should be noted that activity-dependent regulation of KAR alters the synaptic expression of GluA1 and GluA2 AMPARs, while GluK2 editing specifically alters the basal synaptic expression of GluA1 and GluA3 containing AMPARs.24,38 Importantly, these changes were specific to AMPARs, since synaptic levels of the NMDAR subunits GluN1 and GluN2A were unchanged, indicating the loss of AMPARs is not due to wholescale changes in synaptic composition in the editing-deficient mice.
These findings demonstrate that KAR activity mediates the ‘tone’ of synaptic AMPARs at MF-CA3 and Schaffer collateral synapses and suggests a wider role where KAR signaling may set the tone for synaptic AMPAR composition more broadly. We speculate that this may be a homeostatic mechanism in which the presence of high-conductance, Ca2+-permeable GluK2(Q)-containing KARs causes a compensatory decrease in Ca2+-permeable GluA1/GluA3-containing AMPARs to balance synaptic responsiveness.
Unlike recombinant systems or manipulated primary neuronal cultures, the transgenic mice we use have a germline mutation. Thus, the overwhelming majority of GluK2 is unedited throughout development. Therefore, the downregulation of KAR subunit synaptic expression could be a homeostatic mechanism to minimize the excitotoxic effects of Ca2+ entry through the Ca2+-permeable receptors. While we did not assess how AMPAR subunit expression and activity is altered through development in GluK2(Q) compared to WT mice, we suggest that this may correlate with the observed effects of KAR signaling on expression of AMPARs during the development of synaptic circuits,50,69 and our results indicate that this developmental regulation may extend into adulthood. Furthermore, although we have not investigated this directly, it remains possible that altered KAR signaling and reduction in GluA1 and GluA3 AMPAR subunits could impact neuronal development and network formation.
In healthy adult brain GluK2-containing KARs predominantly comprise edited GluK2(R).70 Using mice that almost exclusively express only GluK2(Q) we show that the ionotropic/metabotropic balance of KAR signaling is radically altered by a lack of GluK2 editing. Based on these results, we propose that unedited GluK2(Q)-containing KARs primarily or exclusively function as ion channels with enhanced conductance for both mono and/or di-valent cations, whereas the edited GluK2(R)-containing KARs act as metabotropic receptors to regulate and maintain network activity.
These findings are important because GluK2 Q/R editing is subject to both developmental and activity-dependent control.36 Moreover, it has been reported that the proportion of edited GluK2(R) is increased to 85% in patients with a pharmaco-resistant temporal lobe epilepsy (TLE),70 raising the possibility that increased inhibition of IsAHP, and thereby hyperexcitability, could underpin seizure generation. Conversely, reduction in KAR-mediated inhibition of IsAHP in GluK2(Q) mice might render protection against spontaneous seizures.
Taken together our data indicate that physiologically and pathologically relevant alterations in GluK2 editing may dynamically regulate KAR function, signaling mode, maintenance of functional neuronal networks, and set the threshold for the induction of plasticity. Thus, in conclusion, our results highlight that GluK2 Q/R editing acts as a previously unsuspected molecular switch that regulates the enigmatic dual-mode capability of KARs to operate via either ionotropic or metabotropic signaling, to initiate distinct and diverse downstream pathways.
Limitations of the study
We are mindful that this study is mainly electrophysiological and therefore does not address the molecular pathways and mechanisms underlying altered KAR signaling in the absence of GluK2 Q/R editing, and the subsequent reduction in synaptic expression of the GluA1 and GluA3 AMPAR subunits. In addition, although we show altered synaptic expression of KAR subunits, further investigations are required to understand how Q/R editing modulates the composition of functional receptors. We further reveal a reduction in GluA1 and GluA3 subunits, likely indicating that KAR-meditated signaling specifically regulates Ca2+ permeable AMPARs. However, further investigations will be required to address these questions directly.
We believe the data presented provide compelling evidence that GluK2 Q/R editing significantly regulates KAR signaling and synaptic functions at various synapses in the hippocampus. This work, however, is mainly restricted to young animals (P14-P21), and we have yet to identify how a lack of GluK2 Q/R editing affects synaptic function in adults. Thus, a detailed investigation of the molecular pathways, receptor composition, developmental regulation, and modulation of neuronal excitability by ISAHP provide exciting avenues for future research to understand the role of KAR editing in various neurological and neurodevelopmental disorders, and its potential for future therapeutic intervention.
STAR★Methods
Key resources table
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Antibodies | ||
| Rabbit Polyclonal Anti-Glutamate receptor 1 | Millipore | RRID: AB_2113602 |
| Mouse Monoclonal Anti-Glutamate Receptor | BD Pharmingen | 556341 |
| Rabbit Polyclonal Anti-GluA3 | Alomone | RRID: AB_2039883 |
| Rabbit Polyclonal Anti-GluR5 | Millipore | RRID: AB_2279352 |
| Rabbit Monoclonal Anti-GluR6/7,clone NL9 | Millipore | RRID: AB_1587072 |
| Rabbit Polyclonal Anti-KA2/GRIK5 | Millipore | RRID: AB_310100 |
| Rabbit Monoclonal Anti-Neto1 | a kind gift from Prof. Susumu Tomita (Yale, USA) | NA |
| Rabbit Monoclonal Anti-Neto2 | Abcam | RRID: AB_10863520 |
| Rabbit Monoclonal Anti-NMDAR1 | Abcam | RRID: AB_10862307 |
| Rabbit Monoclonal Anti-NMDAR2A | Abcam | RRID: AB_10975154 |
| Mouse Monoclonal Anti β-actin | Sigma | RRID: AB_47674 |
| Chemicals, peptides, and recombinant proteins | ||
| D-AP5 | Tocris | 0106 |
| GYKI 53655 | Hellobio | HB0312 |
| UBP 310 | Tocris | 2079 |
| Picrotoxin | Sigma-Aldrich | P1675 |
| CGP55845 hydrochloride | Hellobio | HB0960 |
| DCG-IV | Tocris | 0975/1 |
| Sucrose | Merck | S038 |
| NaCl | Merck | S3014 |
| KCl | Merck | P5405 |
| NaHCO3 | Merck | S5761 |
| NaH2PO4 | Merck | S3139 |
| D-Glucose | Merck | G7021 |
| CaCl2 | Merck | C5670 |
| MgCl2 | Merck | M4880 |
| HEPES | Merck | H4034 |
| EGTA | Merck | 324626 |
| CsMeSO4 | Merck | C1426 |
| MgATP | Merck | A9187 |
| NaGTP | Merck | G3776 |
| QX314.Cl | Tocris | 2313/50 |
| Spermine | Merck | S4264 |
| K-Gluconate | Merck | P1847 |
| Syn-PER™ Synaptic Protein Extraction Reagent | ThermoFisher | 87793 |
| Experimental models: Organisms/strains | ||
| 129Sv ECS | University of Bristol Animal Services | NA |
| Software and algorithms | ||
| CED Signal 5 | {Anderson, 2007 #831} | https://www.winltp.com/ |
| GraphPad Prism version 9.3 | This paper | https://www.graphpad.com/scientific-software/prism/ |
| LI-COR Biosciences ImageStudio Lite Version 5.2 | {Evans, 2019 #47162}. | https://www.licor.com/bio/image-studio-lite/download |
| Other | ||
| Vibratome | Leica | VT 1200s |
Resource availability
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jeremy Henley (j.m.henley@bristol.ac.uk).
Materials availability
This study did not generate new unique reagents.
Experimental model and study participant details
GluK2 editing-deficient ECS mice and their WT counterparts (129Sv strain) were created at the Salk Institute by mutating the intronic editing complementary sequence (ECS) in the grik2 gene that directs ADAR2-mediated codon substitution in the GluK2 pre-mRNA.44
The mice were housed in groups of 2–4 in standard individually ventilated (IVC) cages in rooms with temperature maintained between 19°C and 23°C and with 12h light and dark cycles. Cages had sawdust, paper nesting and an enriched environment (wooden chews, cardboard tubes etc.). Pups of age P14-P21 were used for the experiments irrespective of sex.
All the animal experiments and procedures were performed in compliance with the UK Animal Scientific Procedures act (1986) and were guided by the Home Office Licensing Team at the University of Bristol. All animal procedures relating to this study were approved by the Animal Welfare and Ethics Review Board at the University of Bristol (approval number UIN/18/004).
All experiments and analysis were performed blinded to mouse genotype.
Method details
Acute hippocampal slice preparation
Cervical dislocation followed by decapitation were performed on P14-21 male and female WT and GluK2(Q) mouse pups. The brain was removed and placed in ice-cold sucrose slicing solution (in mM: Sucrose, 205; KCl, 2.5; NaHCO3, 26; NaH2PO4, 1.25; D-Glucose, 10; CaCl2, 0.5; MgCl2, 5) saturated with 95% O2 and 5% CO2. Hippocampi were carefully removed and transverse sections of 400μm thickness for whole-cell recordings and 500 μm for field recordings were obtained using a vibratome. Slices were kept for recovery in a slice holder containing artificial cerebrospinal fluid (aCSF; in mM: NaCl, 124; KCl, 3; NaHCO3, 24; NaH2PO4, 1.25; D-Glucose, 10; MgSO4, 4; CaCl2, 4) for whole-cell recordings and (aCSF; in mM: NaCl, 124; KCl, 3; NaHCO3, 24; NaH2PO4, 1.25; D-Glucose, 10; MgSO4, 2; CaCl2, 2) for field recordings saturated with 95% O2 and 5% CO2 at 37°C for 20 min and later transferred to room temperature for at least 30 min before performing experiments.
Electrophysiology recordings
Whole cell recordings
Hippocampal slices were placed in a submerged holding chamber continuously perfused with oxygenated aCSF at 36.5°C at a flow rate of 3mL per minute. Hippocampal CA3 pyramidal cells were visually identified using DIC optics and patch-clamped in whole-cell configuration using a pulled Harvard borosilicate glass capillary of resistance 5-7M MΩ filled with either caesium-based whole-cell solution (in mM: NaCl, 8; CsMeSO4, 130; HEPES, 10; EGTA, 0.5; MgATP, 4; NaGTP, 0.3; QX314.Cl, 5; Spermine, 0.1) or K-Gluconate based (in mM: NaCl, 8; KGluconate, 135; HEPES, 10; EGTA, 0.2; MgATP, 2; NaGTP, 0.3) for IsAHP experiments.
The cells were held in voltage clamp mode and evoked EPSCs were obtained by stimulating the mossy fiber pathway with a bipolar stimulating electrode placed in the dentate gyrus hilus layer (or glass monopolar electrode for minimal stimulation experiments). Picrotoxin (50μM) was included in the aCSF to inhibit GABAA receptors (except for CA1 field recordings). Cells with series resistance above 30 MΩ or where series resistance changed by >20% were excluded from analysis. To confirm the purity of mossy fiber inputs, the group-II mGluR agonist DCG-IV (2μM) was bath applied for 5–10 min at the end of experiments with mossy fiber stimulation.26 Recordings were only included in analysis if DCG-IV reduced EPSCs by >70%.
Minimal stimulation
CA3 pyramidal cells
Cells were voltage clamped at −60mV and MF-EPSCs were evoked by moving a mono-polar stimulating electrode filled with caesium-based whole-cell solution (in mM: NaCl, 8; CsMeSO4, 130; HEPES, 10; EGTA, 0.5; MgATP, 4; NaGTP, 0.3; QX314.Cl, 5; Spermine, 0.1) around the inner border of dentate gyrus granule cells until a response was observed. Stimulation intensity was adjusted just above the threshold for activation of a synaptic response. Consecutive traces were recorded at a frequency of 3Hz. No prominent polysynaptic activation was observed using this low intensity stimulation. AMPAR-EPSCs were measured for 5–10 min in the presence of D-APV (50μM) for a minimum of 150 trials. Subsequently, GYKI53655 (40μM) was applied to block AMPAR responses and KAR-EPSCs were measured after 15 min of GYKI53655 application and for 5–10 min and a minimum of 150 trials.
CA1 pyramidal cells
Cells were voltage clamped at −60mV and Schaffer collaterals were evoked by moving a mono-polar stimulating electrode filled with caesium-based whole-cell solution (in mM: NaCl, 8; CsMeSO4, 130; HEPES, 10; EGTA, 0.5; MgATP, 4; NaGTP, 0.3; QX314.Cl, 5; Spermine, 0.1) around the stratum radiatum until a response was observed. Stimulation intensity was adjusted just above the threshold for activation of a synaptic response. Consecutive traces were recorded at a frequency of 1Hz. No prominent polysynaptic activation was observed using this low intensity stimulation. AMPAR-EPSCs were measured for 5–10 min in the presence of D-APV (50μM) for a minimum of 150 trials.
KAR/AMPAR ratio
CA3 pyramidal neurons were voltage clamped at −60mV in the presence of D-APV (50μM). Mossy fibers were stimulated with a burst of 3 stimuli at 167Hz every 20s to evoke AMPAR/KAR-EPSCs. Stable AMPAR-EPSCs were recorded for 20 min and then KAR-EPSCs were recorded for 20 min in the presence of the AMPAR antagonist GYKI53655 (40μM).
Paired-pulse and frequency facilitation
CA3 neurons in acute hippocampal slices were voltage clamped at −70mV in the presence of picrotoxin (50μM). To measure PPF, EPSCs were evoked by pairs of stimuli to mossy fibers at an inter-stimulus interval of 50ms, every 20s. For FF experiments, single stimuli were given at 0.05Hz for 10 min before stimulation frequency was increased to 1Hz for 1 min. After this, stimulation frequency was returned to 0.05Hz. DCG-IV (2μM) was then applied for at least 5 min to assess purity of MF input.
Slow afterhyperpolarizations (IsAHP)
For IsAHP recordings, CA3 pyramidal neurons were voltage clamped at −50mV in the presence of picrotoxin (50μM), D-APV (50μM), CGP55845 (1μM) (Hello Bio: HB0960) and GYKI53655 (40μM). Glass electrodes were filled with whole-cell solution (in mM: NaCl, 8; KGluconate, 135; HEPES, 10; EGTA, 0.2; MgATP, 2; NaGTP, 0.3). IsAHP were induced every 20s by applying a depolarising voltage step to 0mV for 200ms and IsAHP amplitude was measured 300ms after returning the membrane potential to −50mV to avoid measurement of medium afterhyperpolarization (ImAHP). Synaptic activation of KARs was induced by bursts of 10 stimuli at 25Hz to the mossy fibers 500ms prior to the induction of IsAHP.
Field potential recordings
Extracellular field potentials (fEPSPs) were recorded from stratum radiatum in CA1 using a 3–5 MΩ glass pipette filled with aCSF. Two stimulation electrodes (bipolar) were positioned on opposite sides of the recording electrodes equidistant from the pyramidal layer to evoke two independent inputs (Stim1 and Stim2). LTP induction protocol was delivered only to Stim1 and was alternately positioned closer to the CA3 region or to subiculum in different recordings. Paired stimuli (50ms inter-stimulus interval) were given every 10s to each pathway, alternating between the control and test pathway (Stim1 and Stim2). LTP consisted of 20 bursts of 20 stimuli at 200Hz given every 5s. The recordings were performed in the absence of picrotoxin.
Synaptosomal preparations and Western blotting
Synaptosomes were prepared from cerebral hemisphere of P14-21 pups using Syn-PER Reagent. After cervical dislocation followed by decapitation of the pups, the brain was removed and cut into two-halves (along the cerebral hemispheres). The cerebellum was discarded. Each cerebral hemisphere from the pup was weighed and transferred to a glass homogenizer and the required amount of Syn-PER reagent was added to the tissue (10mL of reagent per gram of tissue). The tissue was homogenized on ice with slow stokes (∼10 strokes). The homogenate was transferred to a fresh centrifuge tube and centrifuged at 1200 x g for 10 min at 4°C. The supernatant was transferred to a fresh tube and the pellet was discarded. The supernatant was centrifuged again at 15,000 x g for 20 min at 4°C. The supernatant was discarded, and the pellet was resuspended in 1-2mL of Syn-PER reagent. To the synaptosomal fraction, Triton X-100 and SDS were added to a final concentration of 1% and 0.1%, respectively, and left at 4°C on a rotating wheel for 1h to lyse synaptosomes and solubilize membrane proteins. The samples were then centrifuged at 16,000 x g for 20 min to remove insoluble material. Protein quantification was performed on the samples and the final samples for Western blotting were prepared by adding 2X sample buffer and boiling at 95°C for 10 min.
The samples prepared were separated based on molecular weight using Sodium dodecyl sulphate-poly acrylamide gel electrophoresis (SDS-PAGE). The gel comprised a 10% acrylamide resolving gel (375mM Tris-HCL pH 8.8, 10% acrylamide, 0.1% SDS, 0.1% APS and 0.01% TEMED) and 5% stacking gel (125mM Tris-HCL pH 6.8, 5% acrylamide, 0.1% SDS, 0.1% APS, 0.01% TEMED).The gels were transferred to PVDF membrane and blocked in 5% skimmed milk in PBS-T (0.137M NaCl, 2.7mM KCl, 10mM Na2HPO4, 2mM K2HPO4, pH to 7.4 with HCl, 0.001% Tween 20) for 1 h at RT and blotted overnight at 4°C in the same blocking solution with the primary antibody.
Quantification and statistical analysis
Electrophysiology recordings
Data acquisition
Data were digitized at 10kHz, and low-pass filtered at 2kHz using CED Micro 1401-4 A-D acquisition unit and Axon patch 200B amplifier (Molecular devices). All recordings were obtained using CED Signal 5 software.
Data analysis
CED Signal acquisition software was used to analyze the recorded data. Mean responses were obtained every minute by averaging consecutive traces. EPSC amplitudes were measured from the averaged traces and normalized to the mean EPSC amplitude of baseline.
Whole cell recordings
CED Signal acquisition software was used to analyze the recorded data. Mean responses were obtained every minute by averaging consecutive traces. EPSC amplitudes were measured from the averaged traces and normalized to the mean EPSC amplitude of baseline.
τdecay
τdecay for AMPAR and KAR-EPSCs were calculated by single exponential curve fitting feature in CED signal software. The equation used is = a0 e −x/a1 + a2. Wherein is regarded as the current as a function of time, a0 is the amplitude at time 0 and a1 is the time constant (τ) and a2 is the steady state current.
KAR/AMPAR ratio
Amplitude of AMPAR-KAR peaks and KAR peaks were measured individually by averaging over a period of 5 min before and after GYKI53655 application and the ratio of KAR-EPSC to AMPAR-EPSC were calculated.
Paired-pulse and frequency facilitation
. Paired-pulse ratios were obtained by averaging amplitudes of P1 peak to P2 peak.
FF ratios were obtained by averaging the last 20 frames of P1 amplitude at 0.05Hz with the middle 40 frames at 1Hz stimulation.
Percentage of DCGIV block
%DCGIV block = (Average baseline P1 peak- Average P1 peak with DCGIV)/Average P1 peak ∗100)
Field potential recordings
fEPSP slopes were measured using CED signal software. The slopes are displayed as a percentage of 10 min baseline. For LTP quantification the values were obtained 21–30 min after LTP induction.
Western blotting
For each experiment, the signal for each condition was divided by the signal from the loading control for that experiment (β-actin). This analysis was performed for each replicate experiment, and for presentation purposes, the mean of the WT is set to 100%.
Statistical analysis
Data are represented as mean ± SEM. ‘N’ - Number of animals used, ‘n’ - number of cells. ANOVA, or paired or un-paired Student’s t test were used for statistical analysis and stated in the figure legends with respective p values. All statistical tests were performed using GraphPad Prism version 9.3.
Acknowledgments
This work was supported by the BBSRC (BB/R00787X/1), the Leverhulme Trust (RPG-2019-191) and the Wellcome Trust (105384/Z/14/A). We are grateful to Prof. Susumu Tomita (Yale, USA) for the kind gift of NETO antibody. The graphical abstract and cartoon was made using Biorender.com.
Author contributions
Conceptualization, J.D.N., K.A.W., J.M., and J.M.H.
Methodology, J.D.N., K.A.W., J.M., and C.M.
Investigation, J.D.N., B.P.Y., and K.A.W.
Writing, J.D.N., K.A.W., J.M., C.M., and J.M.H.
Original Draft and Writing, J.D.N., K.A.W., J.M., and J.M.H.
Review and Editing, All authors.
Funding Acquisition, J.M.H.
Resources, B.V.
Supervision, J.M.H., K.A.W., and J.R.M.
Declaration of interests
The authors declare no competing interests.
Published: August 25, 2023
Footnotes
Supplemental information can be found online at https://doi.org/10.1016/j.isci.2023.107708.
Contributor Information
Jack Mellor, Email: jack.mellor@bristol.ac.uk.
Jeremy M. Henley, Email: j.m.henley@bristol.ac.uk.
Supplemental information
Data and code availability
-
•
Data: All data reported in this paper will be shared by the lead contact upon request.
-
•
Code: This paper does not report original code.
-
•
Experimental model and study participant details: The following animals were generated in salk institute, obtained from Prof Bryce Vissel (Center for Neuroscience and Regenerative Medicine, St Vincent’s Hospital, Sydney, Australia). The animals are currently available at the animal services facility at the University of Bristol.
-
•
Any additional Information: Any additional information required to reanalyze the data reported in this work paper is available from the lead contact upon request.
References
- 1.Evans A.J., Gurung S., Henley J.M., Nakamura Y., Wilkinson K.A. Exciting Times: New Advances Towards Understanding the Regulation and Roles of Kainate Receptors. Neurochem. Res. 2019;44:572–584. doi: 10.1007/s11064-017-2450-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Frerking M., Nicoll R.A. Synaptic kainate receptors. Curr. Opin. Neurobiol. 2000;10:342–351. doi: 10.1016/s0959-4388(00)00094-5. [DOI] [PubMed] [Google Scholar]
- 3.Kullmann D.M. Presynaptic kainate receptors in the hippocampus: slowly emerging from obscurity. Neuron. 2001;32:561–564. doi: 10.1016/s0896-6273(01)00507-4. [DOI] [PubMed] [Google Scholar]
- 4.Lerma J. Roles and rules of kainate receptors in synaptic transmission. Nat. Rev. Neurosci. 2003;4:481–495. doi: 10.1038/nrn1118. [DOI] [PubMed] [Google Scholar]
- 5.Chittajallu R., Vignes M., Dev K.K., Barnes J.M., Collingridge G.L., Henley J.M. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature. 1996;379:78–81. doi: 10.1038/379078a0. [DOI] [PubMed] [Google Scholar]
- 6.Contractor A., Swanson G., Heinemann S.F. Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus. Neuron. 2001;29:209–216. doi: 10.1016/s0896-6273(01)00191-x. [DOI] [PubMed] [Google Scholar]
- 7.Schmitz D., Mellor J., Frerking M., Nicoll R.A. Presynaptic kainate receptors at hippocampal mossy fiber synapses. Proc. Natl. Acad. Sci. USA. 2001;98:11003–11008. doi: 10.1073/pnas.191351498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lauri S.E., Bortolotto Z.A., Bleakman D., Ornstein P.L., Lodge D., Isaac J.T., Collingridge G.L. A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP. Neuron. 2001;32:697–709. doi: 10.1016/s0896-6273(01)00511-6. [DOI] [PubMed] [Google Scholar]
- 9.Kamiya H. Kainate receptor-dependent presynaptic modulation and plasticity. Neurosci. Res. 2002;42:1–6. doi: 10.1016/s0168-0102(01)00303-0. [DOI] [PubMed] [Google Scholar]
- 10.Sachidhanandam S., Blanchet C., Jeantet Y., Cho Y.H., Mulle C. Kainate receptors act as conditional amplifiers of spike transmission at hippocampal mossy fiber synapses. J. Neurosci. 2009;29:5000–5008. doi: 10.1523/JNEUROSCI.5807-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Mulle C., Crépel V. Regulation and dysregulation of neuronal circuits by KARs. Neuropharmacology. 2021;197 doi: 10.1016/j.neuropharm.2021.108699. [DOI] [PubMed] [Google Scholar]
- 12.Negrete-Diaz J.V., Falcon-Moya R., Rodriguez-Moreno A. Kainate receptors: from synaptic activity to disease. FEBS J. 2021 doi: 10.1111/febs.16081. [DOI] [PubMed] [Google Scholar]
- 13.Castillo P.E., Malenka R.C., Nicoll R.A. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature. 1997;388:182–186. doi: 10.1038/40645. [DOI] [PubMed] [Google Scholar]
- 14.Vignes M., Bleakman D., Lodge D., Collingridge G.L. The synaptic activation of the GluR5 subtype of kainate receptor in area CA3 of the rat hippocampus. Neuropharmacol. 1997;36:1477–1481. doi: 10.1016/s0028-3908(97)00158-5. [DOI] [PubMed] [Google Scholar]
- 15.Mulle C., Sailer A., Pérez-Otaño I., Dickinson-Anson H., Castillo P.E., Bureau I., Maron C., Gage F.H., Mann J.R., Bettler B., et al. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature. 1998;392:601–605. doi: 10.1038/33408. [DOI] [PubMed] [Google Scholar]
- 16.Ruiz A., Sachidhanandam S., Utvik J.K., Coussen F., Mulle C. Distinct subunits in heteromeric kainate receptors mediate ionotropic and metabotropic function at hippocampal mossy fiber synapses. J. Neurosci. 2005;25:11710–11718. doi: 10.1523/JNEUROSCI.4041-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Darstein M., Petralia R.S., Swanson G.T., Wenthold R.J., Heinemann S.F. Distribution of kainate receptor subunits at hippocampal mossy fiber synapses. J. Neurosci. 2003;23:8013–8019. doi: 10.1523/JNEUROSCI.23-22-08013.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Salin P.A., Scanziani M., Malenka R.C., Nicoll R.A. Distinct short-term plasticity at two excitatory synapses in the hippocampus. Proc. Natl. Acad. Sci. USA. 1996;93:13304–13309. doi: 10.1073/pnas.93.23.13304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Schmitz D., Mellor J., Nicoll R.A. Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses. Science. 2001;291:1972–1976. doi: 10.1126/science.1057105. [DOI] [PubMed] [Google Scholar]
- 20.Rodríguez-Moreno A., Lerma J. Kainate receptor modulation of GABA release involves a metabotropic function. Neuron. 1998;20:1211–1218. doi: 10.1016/s0896-6273(00)80501-2. [DOI] [PubMed] [Google Scholar]
- 21.Rozas J.L., Paternain A.V., Lerma J. Noncanonical signaling by ionotropic kainate receptors. Neuron. 2003;39:543–553. doi: 10.1016/s0896-6273(03)00436-7. [DOI] [PubMed] [Google Scholar]
- 22.Contractor A., Mulle C., Swanson G.T. Kainate receptors coming of age: milestones of two decades of research. Trends Neurosci. 2011;34:154–163. doi: 10.1016/j.tins.2010.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lerma J., Marques J.M. Kainate receptors in health and disease. Neuron. 2013;80:292–311. doi: 10.1016/j.neuron.2013.09.045. [DOI] [PubMed] [Google Scholar]
- 24.Petrovic M.M., Viana da Silva S., Clement J.P., Vyklicky L., Mulle C., González-González I.M., Henley J.M. Metabotropic action of postsynaptic kainate receptors triggers hippocampal long-term potentiation. Nat. Neurosci. 2017;20:529–539. doi: 10.1038/nn.4505. [DOI] [PubMed] [Google Scholar]
- 25.Melyan Z., Lancaster B., Wheal H.V. Metabotropic regulation of intrinsic excitability by synaptic activation of kainate receptors. J. Neurosci. 2004;24:4530–4534. doi: 10.1523/JNEUROSCI.5356-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Chamberlain S.E.L., Sadowski J.H.L.P., Teles-Grilo Ruivo L.M., Atherton L.A., Mellor J.R. Long-term depression of synaptic kainate receptors reduces excitability by relieving inhibition of the slow afterhyperpolarization. J. Neurosci. 2013;33:9536–9545. doi: 10.1523/JNEUROSCI.0034-13.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Lancaster B., Adams P.R. Calcium-dependent current generating the afterhyperpolarization of hippocampal neurons. J. Neurophysiol. 1986;55:1268–1282. doi: 10.1152/jn.1986.55.6.1268. [DOI] [PubMed] [Google Scholar]
- 28.Fisahn A., Heinemann S.F., McBain C.J. The kainate receptor subunit GluR6 mediates metabotropic regulation of the slow and medium AHP currents in mouse hippocampal neurones. J. Physiol. 2005;562:199–203. doi: 10.1113/jphysiol.2004.077412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rodríguez-Moreno A., Herreras O., Lerma J. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus. Neuron. 1997;19:893–901. doi: 10.1016/s0896-6273(00)80970-8. [DOI] [PubMed] [Google Scholar]
- 30.Cunha R.A., Malva J.O., Ribeiro J.A. Pertussis toxin prevents presynaptic inhibition by kainate receptors of rat hippocampal [(3)H]GABA release. FEBS Lett. 2000;469:159–162. doi: 10.1016/s0014-5793(00)01272-2. [DOI] [PubMed] [Google Scholar]
- 31.Sihra T.S., Rodríguez-Moreno A. Metabotropic actions of kainate receptors in the control of GABA release. Adv. Exp. Med. Biol. 2011;717:1–10. doi: 10.1007/978-1-4419-9557-5_1. [DOI] [PubMed] [Google Scholar]
- 32.Falcón-Moya R., Rodríguez-Moreno A. Metabotropic actions of kainate receptors modulating glutamate release. Neuropharmacology. 2021;197 doi: 10.1016/j.neuropharm.2021.108696. [DOI] [PubMed] [Google Scholar]
- 33.Martin S., Henley J.M. Activity-dependent endocytic sorting of kainate receptors to recycling or degradation pathways. EMBO J. 2004;23:4749–4759. doi: 10.1038/sj.emboj.7600483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.González-González I.M., Henley J.M. Postsynaptic kainate receptor recycling and surface expression are regulated by metabotropic autoreceptor signalling. Traffic. 2013;14:810–822. doi: 10.1111/tra.12071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Evans A.J., Gurung S., Wilkinson K.A., Stephens D.J., Henley J.M. Assembly, Secretory Pathway Trafficking, and Surface Delivery of Kainate Receptors Is Regulated by Neuronal Activity. Cell Rep. 2017;19:2613–2626. doi: 10.1016/j.celrep.2017.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Gurung S., Evans A.J., Wilkinson K.A., Henley J.M. ADAR2-mediated Q/R editing of GluK2 regulates kainate receptor upscaling in response to suppression of synaptic activity. J. Cell Sci. 2018;131 doi: 10.1242/jcs.222273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Nair J.D., Wilkinson K.A., Henley J.M., Mellor J.R. Kainate Receptors and Synaptic Plasticity. Neuropharmacology. 2021;196 doi: 10.1016/j.neuropharm.2021.108540. [DOI] [PubMed] [Google Scholar]
- 38.Nair J.D., Braksator E., Yucel B.P., Fletcher-Jones A., Seager R., Mellor J.R., Bashir Z.I., Wilkinson K.A., Henley J.M. Sustained postsynaptic kainate receptor activation downregulates AMPA receptor surface expression and induces hippocampal LTD. iScience. 2021;24 doi: 10.1016/j.isci.2021.103029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Seeburg P.H., Higuchi M., Sprengel R. RNA editing of brain glutamate receptor channels: mechanism and physiology. Brain Res. Brain Res. Rev. 1998;26:217–229. doi: 10.1016/s0165-0173(97)00062-3. [DOI] [PubMed] [Google Scholar]
- 40.Filippini A., Bonini D., La Via L., Barbon A. The Good and the Bad of Glutamate Receptor RNA Editing. Mol. Neurobiol. 2017;54:6795–6805. doi: 10.1007/s12035-016-0201-z. [DOI] [PubMed] [Google Scholar]
- 41.Pahl S., Tapken D., Haering S.C., Hollmann M. Trafficking of kainate receptors. Membranes. 2014;4:565–595. doi: 10.3390/membranes4030565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ball S.M., Atlason P.T., Shittu-Balogun O.O., Molnár E. Assembly and intracellular distribution of kainate receptors is determined by RNA editing and subunit composition. J. Neurochem. 2010;114:1805–1818. doi: 10.1111/j.1471-4159.2010.06895.x. [DOI] [PubMed] [Google Scholar]
- 43.Swanson G.T., Feldmeyer D., Kaneda M., Cull-Candy S.G. Effect of RNA editing and subunit co-assembly single-channel properties of recombinant kainate receptors. J. Physiol. 1996;492:129–142. doi: 10.1113/jphysiol.1996.sp021295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Vissel B., Royle G.A., Christie B.R., Schiffer H.H., Ghetti A., Tritto T., Perez-Otano I., Radcliffe R.A., Seamans J., Sejnowski T., et al. The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron. 2001;29:217–227. doi: 10.1016/s0896-6273(01)00192-1. [DOI] [PubMed] [Google Scholar]
- 45.Bowie D., Mayer M.L. Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyamine-mediated ion channel block. Neuron. 1995;15:453–462. doi: 10.1016/0896-6273(95)90049-7. [DOI] [PubMed] [Google Scholar]
- 46.Kamboj S.K., Swanson G.T., Cull-Candy S.G. Intracellular spermine confers rectification on rat calcium-permeable AMPA and kainate receptors. J. Physiol. 1995;486:297–303. doi: 10.1113/jphysiol.1995.sp020812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Egebjerg J., Kukekov V., Heinemann S.F. Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequence. Proc. Natl. Acad. Sci. USA. 1994;91:10270–10274. doi: 10.1073/pnas.91.22.10270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Paschen W., Schmitt J., Gissel C., Dux E. Developmental changes of RNA editing of glutamate receptor subunits GluR5 and GluR6: in vivo versus in vitro. Brain Res. Dev. Brain Res. 1997;98:271–280. doi: 10.1016/s0165-3806(96)00193-9. [DOI] [PubMed] [Google Scholar]
- 49.Marchal C., Mulle C. Postnatal maturation of mossy fibre excitatory transmission in mouse CA3 pyramidal cells: a potential role for kainate receptors. J. Physiol. 2004;561:27–37. doi: 10.1113/jphysiol.2004.069922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Lanore F., Labrousse V.F., Szabo Z., Normand E., Blanchet C., Mulle C. Deficits in morphofunctional maturation of hippocampal mossy fiber synapses in a mouse model of intellectual disability. J. Neurosci. 2012;32:17882–17893. doi: 10.1523/JNEUROSCI.2049-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Stevens C.F., Wang Y. Facilitation and depression at single central synapses. Neuron. 1995;14:795–802. doi: 10.1016/0896-6273(95)90223-6. [DOI] [PubMed] [Google Scholar]
- 52.Dobrunz L.E., Huang E.P., Stevens C.F. Very short-term plasticity in hippocampal synapses. Proc. Natl. Acad. Sci. USA. 1997;94:14843–14847. doi: 10.1073/pnas.94.26.14843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Dobrunz L.E., Stevens C.F. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron. 1997;18:995–1008. doi: 10.1016/s0896-6273(00)80338-4. [DOI] [PubMed] [Google Scholar]
- 54.Martin S., Nishimune A., Mellor J.R., Henley J.M. SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature. 2007;447:321–325. doi: 10.1038/nature05736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Contractor A., Swanson G.T., Sailer A., O'Gorman S., Heinemann S.F. Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus. J. Neurosci. 2000;20:8269–8278. doi: 10.1523/JNEUROSCI.20-22-08269.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Rodríguez-Moreno A., Sihra T.S. Presynaptic kainate receptor facilitation of glutamate release involves protein kinase A in the rat hippocampus. J. Physiol. 2004;557:733–745. doi: 10.1113/jphysiol.2004.065029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Breustedt J., Schmitz D. Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. J. Neurosci. 2004;24:10093–10098. doi: 10.1523/JNEUROSCI.3078-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Regehr W.G., Delaney K.R., Tank D.W. The role of presynaptic calcium in short-term enhancement at the hippocampal mossy fiber synapse. J. Neurosci. 1994;14:523–537. doi: 10.1523/JNEUROSCI.14-02-00523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Kamiya H., Ozawa S. Dual mechanism for presynaptic modulation by axonal metabotropic glutamate receptor at the mouse mossy fibre-CA3 synapse. J. Physiol. 1999;518:497–506. doi: 10.1111/j.1469-7793.1999.0497p.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Melyan Z., Wheal H.V. Metabotropic actions of kainate receptors in the regulation of I(sAHP) and excitability in CA1 pyramidal cells. Adv. Exp. Med. Biol. 2011;717:49–58. doi: 10.1007/978-1-4419-9557-5_5. [DOI] [PubMed] [Google Scholar]
- 61.Pinheiro P.S., Lanore F., Veran J., Artinian J., Blanchet C., Crépel V., Perrais D., Mulle C. Selective block of postsynaptic kainate receptors reveals their function at hippocampal mossy fiber synapses. Cereb. Cortex. 2013;23:323–331. doi: 10.1093/cercor/bhs022. [DOI] [PubMed] [Google Scholar]
- 62.Copits B.A., Swanson G.T. Dancing partners at the synapse: auxiliary subunits that shape kainate receptor function. Nat. Rev. Neurosci. 2012;13:675–686. doi: 10.1038/nrn3335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.van Zundert B., Yoshii A., Constantine-Paton M. Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal. Trends Neurosci. 2004;27:428–437. doi: 10.1016/j.tins.2004.05.010. [DOI] [PubMed] [Google Scholar]
- 64.Behrens C.J., van den Boom L.P., de Hoz L., Friedman A., Heinemann U. Induction of sharp wave-ripple complexes in vitro and reorganization of hippocampal networks. Nat. Neurosci. 2005;8:1560–1567. doi: 10.1038/nn1571. [DOI] [PubMed] [Google Scholar]
- 65.Bernard A., Ferhat L., Dessi F., Charton G., Represa A., Ben-Ari Y., Khrestchatisky M. Q/R editing of the rat GluR5 and GluR6 kainate receptors in vivo and in vitro: evidence for independent developmental, pathological and cellular regulation. Eur. J. Neurosci. 1999;11:604–616. doi: 10.1046/j.1460-9568.1999.00479.x. [DOI] [PubMed] [Google Scholar]
- 66.Rutkowska-Wlodarczyk I., Aller M.I., Valbuena S., Bologna J.C., Prézeau L., Lerma J. A Proteomic Analysis Reveals the Interaction of GluK1 Ionotropic Kainate Receptor Subunits with Go Proteins. J. Neurosci. 2015;35:5171–5179. doi: 10.1523/JNEUROSCI.5059-14.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Pinheiro P.S., Perrais D., Coussen F., Barhanin J., Bettler B., Mann J.R., Malva J.O., Heinemann S.F., Mulle C. GluR7 is an essential subunit of presynaptic kainate autoreceptors at hippocampal mossy fiber synapses. Proc. Natl. Acad. Sci. USA. 2007;104:12181–12186. doi: 10.1073/pnas.0608891104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Lyon L., Borel M., Carrión M., Kew J.N.C., Corti C., Harrison P.J., Burnet P.W.J., Paulsen O., Rodríguez-Moreno A. Hippocampal mossy fiber long-term depression in Grm2/3 double knockout mice. Synapse. 2011;65:945–954. doi: 10.1002/syn.20923. [DOI] [PubMed] [Google Scholar]
- 69.Lauri S.E., Delany C., J Clarke V.R., Bortolotto Z.A., Ornstein P.L., T R Isaac J., Collingridge G.L. Synaptic activation of a presynaptic kainate receptor facilitates AMPA receptor-mediated synaptic transmission at hippocampal mossy fibre synapses. Neuropharmacology. 2001;41:907–915. doi: 10.1016/s0028-3908(01)00152-6. [DOI] [PubMed] [Google Scholar]
- 70.Kortenbruck G., Berger E., Speckmann E.J., Musshoff U. RNA editing at the Q/R site for the glutamate receptor subunits GLUR2, GLUR5, and GLUR6 in hippocampus and temporal cortex from epileptic patients. Neurobiol. Dis. 2001;8:459–468. doi: 10.1006/nbdi.2001.0394. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
-
•
Data: All data reported in this paper will be shared by the lead contact upon request.
-
•
Code: This paper does not report original code.
-
•
Experimental model and study participant details: The following animals were generated in salk institute, obtained from Prof Bryce Vissel (Center for Neuroscience and Regenerative Medicine, St Vincent’s Hospital, Sydney, Australia). The animals are currently available at the animal services facility at the University of Bristol.
-
•
Any additional Information: Any additional information required to reanalyze the data reported in this work paper is available from the lead contact upon request.






